ESTUDIO MULTICENTRICO, RANDOMIZADO, EN DOBLE CIEGO, CONTROLADO CON PLACEBO, DE HALLAZGO DE DOSIS Y DE LA SEGURIDAD Y EFICACIA DEL LIGADO GLICOPROTEICO RECOMBINANTE DE LA SELECTINA P E INMUNOGLOBULINA EN COMBINACION CON TRATAMIENTO TROMBOLITICO EN PACIENTES CON INFARTO AGUDO DE MIOCARDIO.

[Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].

Estella, Angel; (...); Zaragoza, Rafael

Article. 10.1016/j.medin.2021.04.007. 2021

• 
• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 12
  • Captures
    • Readers: 98
  • Mentions
    • News Mentions: 1
  • Social Media
    • Shares, Likes & Comments: 2

  see details
• 8

  

[Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units].

Vidal-Cortes, Pablo; (...); Crespo, Rafael Zaragoza

Article. 10.1016/j.medin.2021.08.011. 2021

• 
• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 20
  • Captures
    • Readers: 148
  • Mentions
    • News Mentions: 1
  • Social Media
    • Shares, Likes & Comments: 40

  see details
• 28

  

Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.

Villarreal, E.; (...); Vila, J.

Article. 10.1016/j.medine.2022.04.019. 2022

Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.

Ruiz-Ramos, Jesus, Gras-Martin, Laura, Ramirez, Paula

Article. 10.3390/antibiotics12030475. 2023

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 6
  • Captures
    • Readers: 27
  • Mentions
    • Blog Mentions: 1
    • News Mentions: 1

  see details
• 7

  

Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.

Cercenado, Emilia; (...); Retamar-Gentil, Pilar

Practice Guideline. 10.1016/j.eimce.2022.05.013. 2023

• 
• PlumX Metrics

  

  • Citations
    • Citation Indexes: 8
  • Captures
    • Readers: 26
  • Mentions
    • News Mentions: 1

  see details
• 21

  

Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP

Cercenado, Emilia; (...); Retamar-Gentil, Pilar

Editorial Material. 10.1016/j.eimc.2022.05.005. 2023

• 
• 20

  

Antimicrobial stewardship programs in the intensive care unit in patients with infections caused by multidrug-resistant gram-negative bacilli

Ramos, J. Ruiz, Galleymore, P. Ramirez

Article. 10.1016/j.medin.2022.07.007. 2023

• 1

  

Antimicrobial stewardship programs in the Intensive Care Unit in patients with infections caused by multidrug-resistant Gram-negative bacilli.

Ruiz-Ramos J, Ramírez P

Article. 10.1016/j.medine.2022.09.004. 2022

• 
• 4

  

Beyond the Pandemic: The Value of Antimicrobial Stewardship

Kanj, Souha S., Ramirez, Paula, Rodrigues, Camilla

Article. 10.3389/fpubh.2022.902835. 2022

• 
• 
• 6

  

Biomarkers in pulmonary infections: a clinical approach.

Povoa, Pedro; (...); Kalil, Andre C

Article. 10.1186/s13613-024-01323-0. 2024

• 
• 
• 7

  

Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support.

Marín-Cerezuela M; (...); Ramirez P

Letter. 10.1186/s13054-024-05126-4. 2024

Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.

Martin-Cerezuela, M; (...); Galleymore, P R

Article. 10.1016/j.medin.2021.05.011. 2021

• 3

  

Ceftaroline versus standard therapy for pneumococcal meningitis in critically ill patients.

Martín-Cerezuela M; (...); Galleymore PR

Article. 10.1016/j.medine.2021.05.007. 2022

• 4

  

Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry

Madero Velazquez, L.; (...); Gutierrez-Casbas, A.

Meeting Abstract. 2024

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.3390/biomedicines12092109. 2024

Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.08.040. 2021

• 1

  

Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.

Vidal-Cortes, Pablo; (...); Zaragoza, Rafael

Review. 10.3390/antibiotics11091160. 2022

• 
• 
• 15

  

Decolonization strategies against multidrug resistant organisms in the ICU.

Póvoa P, Ramirez P, Blot S

Editorial Material. 10.1007/s00134-024-07360-4. 2024

Efficacy and Experience of Bacteriophages in Biofilm-Related Infections.

Gordon, Monica, Ramirez, Paula

Article. 10.3390/antibiotics13020125. 2024

• 
• 
• 5

  

Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia.

Ceccato, Adrian; (...); Artigas, Antonio

Article. 10.3390/biomedicines11102676. 2023

• 
• 
• 1

  

Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption

Talavera, Monica; (...); Ramirez, Paula

Letter. 10.1016/j.medin.2023.04.013. 2023

• 
• 1

  

Four cases of unexpected severe community-acquired pneumonia aetiology: Group A Streptococcus pyogenes disruption.

Talavera, Monica; (...); Ramirez, Paula

Case Reports. 10.1016/j.medine.2023.05.004. 2023

• 2

  

How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.

Povoa, Pedro; (...); Kalil, Andre C.

Article. 10.1007/s00134-022-06956-y. 2023

• 
• 
• 154

  

Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.

Álvarez-Lerma F; (...); Martínez-Alonso M

Article. 10.1016/j.medine.2022.12.002. 2023

• 
• 10

  

Impact of the ?Zero Resistance? program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study

Alvarez-Lerma, Francisco; (...); Martinez-Alonso, Montserrat

Article. 10.1016/j.medin.2022.12.002. 2023

• 9

  

Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU.

Estella, A; (...); Zaragoza, R

Article. 10.1016/j.medine.2021.08.013. 2021

• 
• 
• 17

  

New evidence in severe pneumonia: meropenem-vaborbactam.

Forteza Guillot, Maria, Martin Cerezuela, Maria, Ramirez, Paula

Article. 10.37201/req/s01.10.2022. 2022

• 
• 3

  

Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.

Vidal-Cortés P; (...); Zaragoza Crespo R

Practice Guideline. 10.1016/j.medine.2021.11.019. 2022

• 
• 
• 21

  

Severe community-acquired Streptococcus pneumoniae bacterial meningitis: clinical and prognostic picture from the intensive care unit.

Martín-Cerezuela M; (...); Ramírez-Galleymore P

Article. 10.1186/s13054-023-04347-3. 2023

• 
• 
• 11

  

Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.

Candel, Francisco Javier; (...); Zaragoza, Rafael

Article. 10.3390/jcm12206526. 2023

• 
• 
• 11

  

Textbook outcome in patients with biliary duct injury during cholecystectomy.

Lopez-Lopez V; (...); Robles-Campos R

Article. 10.1016/j.gassur.2024.02.027. 2024

• 
• 1

  

The challenge of multiresistant microorganisms.

Vicent C, Ramírez P

Editorial Material. 10.1016/j.medcli.2023.12.004. 2024

• 
• 
• 2

  

Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients.

Martin-Loeches I; (...); Bermejo-Martín JF

Article. 10.1080/14787210.2023.2256979. 2023

• 
• 1

  

Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence.

Viale, Pierluigi; (...); Lodise, Thomas P.

Article. 10.1186/s13613-023-01146-5. 2023

• 
• 
• 30